Summary by Moomoo AI
Zhong Ji Changshou Scientific Group Limited announced its unaudited interim results for the six months ended June 30, 2024, showing a 41.8% increase in revenue to HK$42.4 million, a 25.6% increase in gross profit to HK$33.3 million, but a 85.9% decrease in profit before tax to HK$0.7 million. Net assets slightly increased to HK$432.1 million, and no interim dividend was proposed. The company's main businesses include long-life science business, lending and financial consulting business, securities and other investments, and property investments. During the period, the revenue of the long-life science business was approximately HK$25.18 million, while the revenue of the lending and financial consulting business was HK$17.22 million. The company's shares are listed on The Stock Exchange of Hong Kong Limited and have strengthened the development of the long-life science business during the period, including establishing a strategic partnership with Thermo Fisher Scientific (Hong Kong) Limited. After the reporting period, there were no significant events occurring.